acute%20coronary%20syndromes%20w_out%20persistent%20st-segment%20elevation
ACUTE CORONARY SYNDROMES W/OUT PERSISTENT ST-SEGMENT ELEVATION
Acute coronary syndromes refer to any constellation of clinical symptoms compatible with acute myocardial ischemia which may be life-threatening.
It encompasses unstable angina, non-ST-segment elevation myocardial infarction (NSTEMI) and ST-segment elevation myocardial infarction (STEMI).
Unstable angina is the ischemic discomfort that presents without persistent ST-segment elevation on ECG and without the presence of cardiac markers in the blood.
Non-ST-segment elevation myocardial infarction is diagnosed if cardiac markers are positive with ST-segment depression or with nonspecific or normal ECGs.
The patient typically presents with ischemic-type chest pain that is severe and prolonged and may occur at rest or may be caused by less exertion than previous episodes.
Drug Information

Indication: HTN, vasospastic (Prinzmetal's or variant angina) or chronic stable angina.

Indication: 1st-line treatment of HTN & myocardial ischaemia. Monotherapy or in combination w/ other antianginal drugs...

Indication: 1st-line treatment of HTN & myocardial ischemia whether due to fixed obstruction (stable angina) &/or ...

Indication: HTN. 1st-line treatment of myocardial ischemia in fixed obstruction (stable angina) &/or vasoconstriction/...

Indication: Prevention of venous thromboembolic events (VTE) in patients undergoing major orthopaedic surgery of the lower...

Dosage: HTN 50-100 mg daily as single dose. Arrhythmia Oral maintenance: 50-100 mg daily as single dose. Angina 50 mg

Indication: 1st-line treatment for HTN as monotherapy or combination w/ other antihypertensive agents; myocardial ischemia...

Indication: HTN; angina pectoris; MI. Disturbances of cardiac rhythm including supraventricular tachycardia. Functional he...

Indication: HTN, CHD (angina pectoris), stable chronic heart failure w/ reduced systolic left ventricular function in addi...

Indication: 2.5 & 5 mg: Stable chronic heart failure w/ reduced systolic left ventricular function. 5 mg: HTN & CH...

2  /  16
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS Cardiology - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
Pearl Toh, 15 Apr 2020
Transcatheter aortic valve replacement (TAVR) in patients with bicuspid aortic stenosis who are at low surgical risk appears to be safe with low rates of death or disabling stroke at 30 days, according to a study presented at the ACC.20/WCC Virtual Meeting.